MapLight Therapeutics, Inc. (NASDAQ:MPLT) Financings

MapLight Therapeutics, Inc.

Financings

RaiseDate
Private placement of common stock and pre-funded warrants
Announced: about US$150M · US$11.38 a share · Morgan Stanley +3
Dealers: Morgan Stanley, Jefferies, Leerink Partners, Stifel
Use of proceeds: Advance ML-007C-MA, including the VISTA Phase 2 and ZEPHYR-2 Phase 3 studies, plus working capital and general corporate purposes
Aug 13, 2026
Public offering of common stock
Closed: US$17 a share · Morgan Stanley +3
Dealers: Morgan Stanley (co-lead), Jefferies (co-lead), Leerink Partners (co-lead), Stifel (co-lead)
Oct 29, 2025
Private placement of common stock
Closed: US$17 a share
Buyers: Affiliates of Goldman Sachs & Co. LLC (476,707 shares of common stock, including certain investment funds managed by Goldman Sachs & Co. LLC)
Oct 29, 2025

Read by 6ix AI from the company's releases